# S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

> **NCT01598298** · PHASE3 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 299 (actual)

## Conditions studied

- Breast Cancer
- Musculoskeletal Complications
- Pain

## Interventions

- **DRUG:** duloxetine hydrochloride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01598298
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-15
- **Primary completion:** 2016-12-01
- **Final completion:** 2018-12-20
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2022-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01598298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01598298, "S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01598298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*